Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants
Sponsor: Novartis Pharmaceuticals
Summary
This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.
Official title: A Prospective Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants With Symptomatic Cryptosporidiosis in Endemic Countries
Key Details
Gender
All
Age Range
6 Months - 59 Months
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-01-09
Completion Date
2027-05-19
Last Updated
2026-07-21
Healthy Volunteers
No
Conditions
Locations (4)
Novartis Investigative Site
Kisumu, Nyanza, Kenya
Novartis Investigative Site
Kuantan, Pahang, Malaysia
Novartis Investigative Site
Kuala Lumpur, Malaysia
Novartis Investigative Site
Lusaka, Zambia